A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 24 ·No. 13 ·2006-05-01 ·Pages 2127; author reply 2127-8

Kumar AS, Campbell M, Benz CC, Esserman LJ

Abstract

暂无摘要

MeSH Terms

Breast Neoplasms/drug therapy,prevention & control Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use Receptors, Estrogen/analysis

Chemicals

Hydroxymethylglutaryl-CoA Reductase Inhibitors Receptors, Estrogen

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Kumar Anjali S

Campbell Michael

Benz Christopher C

Esserman Laura J

Article Info

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Abbr.

J Clin Oncol

ISSN

1527-7755

DOI

10.1200/JCO.2005.04.9882

Published

2006-05-01

Pages

2127; author reply 2127-8

Language

English

Region

United States

NLM ID

8309333

Subset

Corrections

CommentOn

PMID: 16260694

External Links

PubMed source DOI: 10.1200/JCO.2005.04.9882 View journal details

Analysis Services

A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.

Contact

WeChat Official Account